The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for Z Peng


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and biological evaluation of novel 2,4,5-triarylimidazole-1,2,3-triazole derivatives via click chemistry asa-glucosidase inhibitors.EBI
Jishou University
Identification of a novel aminotetralin class of HDAC6 and HDAC8 selective inhibitors.EBI
Roche Pharmaceutical Research and Early Development
Degrasyn-like symmetrical compounds: possible therapeutic agents for multiple myeloma (MM-I).EBI
The University of Texas M.D. Anderson Cancer Center
Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level.EBI
The University of Texas M.D. Anderson Cancer Center
Pharmacokinetic optimization of class-selective histone deacetylase inhibitors and identification of associated candidate predictive biomarkers of hepatocellular carcinoma tumor response.EBI
Roche R & D Center China
Structure-based design and synthesis of (5-arylamino-2H-pyrazol-3-yl)-biphenyl-2',4'-diols as novel and potent human CHK1 inhibitors.EBI
Pfizer
2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity.EBI
Astrazeneca Pharmaceuticals
Application of p21 and klf2 reporter gene assays to identify selective histone deacetylase inhibitors for cancer therapy.EBI
Roche R & D Center China
Synthesis, biological evaluation and action mechanism of 7H-[1,2,4] triazolo [3,4-b] [1,3,4] thiadiazine-phenylhydrazone derivatives as α-glucosidase inhibitors.EBI
The Affiliated Hospital of Guizhou Medical University
Anticancer potential of active alkaloids and synthetic analogs derived from marine invertebrates.EBI
Chengdu University of Traditional Chinese Medicine
Novel carbazole-oxadiazole derivatives as anti-α-glucosidase and anti-α-amylase agents: Design, synthesis, molecular docking, and biological evaluation.EBI
Guizhou Medical University
Design, synthesis and biological evaluation of biaryl amide derivatives against SARS-CoV-2 with dual-target mechanism.EBI
Chinese Academy of Medical Sciences and Peking Union Medical College
Design, Synthesis, and Evaluation of EBI
Chongqing Medical University
Development of [EBI
Chongqing Medical University
An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.EBI
Guizhou Medical University
Occurrence, synthesis and biological activity of 2-(2-phenyethyl)chromones.EBI
Guizhou Medical University
Harzianoic acids A and B, new natural scaffolds with inhibitory effects against hepatitis C virus.EBI
Peking University
Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR.EBI
Wuxi Apptec (Shanghai) Co.
Synthesis, in vitro evaluation and molecular docking studies of novel triazine-triazole derivatives as potentialα-glucosidase inhibitors.EBI
Jishou University
JNK modulatorsBDB
Hoffmann-La Roche
Design of a carbonic anhydrase IX active-site mimic to screen inhibitors for possible anticancer properties.BDB
University of Florida
Effects of norepinephrine and serotonin transporter inhibitors on hyperactivity induced by neonatal 6-hydroxydopamine lesioning in rats.BDB
Harvard University